Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.
Following the conventional 12-18 month antithyroid drug (ATD) treatment in Graves' disease (GD), 50% of patients experience relapse of hyperthyroidism.The aim of this systematic scoping rev...